Evonik Industries AG (EVK) - Total Liabilities

Latest as of December 2025: €9.81 Billion EUR ≈ $11.47 Billion USD

Based on the latest financial reports, Evonik Industries AG (EVK) has total liabilities worth €9.81 Billion EUR (≈ $11.47 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Evonik Industries AG - Total Liabilities Trend (2013–2025)

This chart illustrates how Evonik Industries AG's total liabilities have evolved over time, based on quarterly financial data. See Evonik Industries AG (EVK) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Evonik Industries AG Competitors by Total Liabilities

The table below lists competitors of Evonik Industries AG ranked by their total liabilities.

Company Country Total Liabilities
EVONIK INDUST.(U.ARD)2
F:EVKA
Germany €9.81 Billion
BRENNTAG SE UNSP.ADR/020
F:BNRA
Germany €6.28 Billion
Beijing Jingneng Power Co Ltd
SHG:600578
China CN¥64.24 Billion
SailPoint, Inc. Common Stock
NASDAQ:SAIL
USA $751.33 Million
Figma, Inc.
NYSE:FIG
USA $837.57 Million
CIG ShangHai Co Ltd Class A
SHG:603083
China CN¥3.60 Billion
FactSet Research Systems Inc
NYSE:FDS
USA $2.09 Billion
Full Truck Alliance Co Ltd ADR
NYSE:YMM
USA $3.62 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Evonik Industries AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Evonik Industries AG.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.49 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.21 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.55 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Evonik Industries AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Evonik Industries AG (2013–2025)

The table below shows the annual total liabilities of Evonik Industries AG from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 €9.81 Billion
≈ $11.47 Billion
-7.92%
2024-12-31 €10.65 Billion
≈ $12.45 Billion
-2.78%
2023-12-31 €10.95 Billion
≈ $12.81 Billion
+1.86%
2022-12-31 €10.75 Billion
≈ $12.57 Billion
-16.71%
2021-12-31 €12.91 Billion
≈ $15.10 Billion
+0.89%
2020-12-31 €12.80 Billion
≈ $14.96 Billion
-1.27%
2019-12-31 €12.96 Billion
≈ $15.16 Billion
+4.06%
2018-12-31 €12.46 Billion
≈ $14.56 Billion
+0.36%
2017-12-31 €12.41 Billion
≈ $14.51 Billion
+4.35%
2016-12-31 €11.89 Billion
≈ $13.91 Billion
+26.15%
2015-12-31 €9.43 Billion
≈ $11.02 Billion
+2.90%
2014-12-31 €9.16 Billion
≈ $10.71 Billion
+1.28%
2013-12-31 €9.05 Billion
≈ $10.58 Billion
--

About Evonik Industries AG

F:EVK Germany Specialty Chemicals
Market Cap
$8.52 Billion
€7.29 Billion EUR
Market Cap Rank
#2665 Global
#527 in Germany
Share Price
€15.64
Change (1 day)
-0.76%
52-Week Range
€12.57 - €18.49
All Time High
€25.23
About

Evonik Industries AG operates as a chemicals company in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. It operates through the Advanced Technologies, Custom Solutions, and Infrastructure segments. The Advanced Technologies segment provides polymers for medical applications; crosslinkers; hydrogen peroxide, a sterilizing agent for cleaning silicon wafers and a bleaching agent… Read more